ampelopsin has been researched along with acetaminophen in 1 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (acetaminophen) | Trials (acetaminophen) | Recent Studies (post-2010) (acetaminophen) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 20,696 | 2,848 | 8,242 |
| Protein | Taxonomy | ampelopsin (IC50) | acetaminophen (IC50) |
|---|---|---|---|
| Myoglobin | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, S; Hu, L; Ji, J; Wang, H | 1 |
1 other study(ies) available for ampelopsin and acetaminophen
| Article | Year |
|---|---|
Dihydromyricetin alleviates acetaminophen-induced liver injury via the regulation of transformation, lipid homeostasis, cell death and regeneration.
Topics: Acetaminophen; Animals; Cell Death; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Flavonols; Glutathione; Hepatocytes; Homeostasis; Lipid Metabolism; Lipids; Liver; Liver Regeneration; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Signal Transduction | 2019 |